Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Bolli · SciRah

Researcher profile · Semantic Scholar

N. Bolli

Share profile

N. Bolli — researcher profile on SciRah

h-index: 50
Works: 265
Citations: 24K

Most-cited papers

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
H. Avet-Loiseau, Faith E. Davies, Mehmet K. Samur, J. Corre +42 more
2025Journal of Clinical Oncology189 citations Open access
Semantic Scholar
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
E. Sauta, M. Robin, M. Bersanelli, E. Travaglino +44 more
2023Journal of Clinical Oncology187 citations Open access
Semantic Scholar
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
M. Bersanelli, E. Travaglino, M. Meggendorfer, Tommaso Matteuzzi +42 more
2021Journal of Clinical Oncology179 citations Open access
Semantic Scholar
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Bénedith Oben, G. Froyen, K. Maclachlan, D. Leongamornlert +23 more
2021Nature Communications106 citations Open access
Semantic Scholar
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Francesco Maura, A. Rajanna, B. Ziccheddu, A. Poos +33 more
2024Journal of Clinical Oncology89 citations Open access
Semantic Scholar
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures.
B. Diamond, B. Ziccheddu, K. Maclachlan, Justin Taylor +29 more
2022Blood50 citations Open access
Semantic Scholar
mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies
E. Rustad, F. Nadeu, Nicos Angelopoulos, B. Ziccheddu +5 more
2021Communications Biology39 citations Open access
Semantic Scholar
European Myeloma Network Group Review and Consensus Statement on Primary Plasma Cell Leukemia.
P. Musto, M. Engelhardt, N. W. van de Donk, F. Gay +27 more
2025Annals of Oncology26 citations Open access
Semantic Scholar
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers
D. Ronchetti, Valentina Traini, Ilaria Silvestris, G. Fabbiano +3 more
2024Cancer Gene Therapy23 citations Open access
Semantic Scholar
Circulating biomarkers in familial cerebral cavernous malformation
F. Lazzaroni, J. Meessen, Ying Sun, S. Lanfranconi +28 more
2023EBioMedicine23 citations Open access
Semantic Scholar
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins
E. Taiana, C. Bandini, V. Favasuli, D. Ronchetti +12 more
2022Haematologica22 citations Open access
Semantic Scholar
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity.
A. Sacco, C. Federico, K. Todoerti, B. Ziccheddu +30 more
2021Blood20 citations Open access
Semantic Scholar
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
B. Ziccheddu, Claudia Giannotta, M. D'Agostino, G. Bertuglia +14 more
2024Blood Cancer Journal19 citations Open access
Semantic Scholar
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy
Maria Moscvin, C. Liacos, Tian-Zeng Chen, F. Theodorakakou +13 more
2021Blood Cancer Journal19 citations Open access
Semantic Scholar
Genomics define malignant transformation in myeloma precursor conditions
Francesco Maura, P. Bergsagel, B. Ziccheddu, Shaji K. Kumar +40 more
2025Journal of Clinical Oncology18 citations Open access
Semantic Scholar
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study
E. Martino, D. Derudas, Elena Rossi, P. Stefanoni +38 more
2025Hematological Oncology16 citations Open access
Semantic Scholar
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease
A. Marchetti, S. Pelusi, A. Marella, F. Malvestiti +20 more
2024Hepatology15 citations Open access
Semantic Scholar
Single Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma.
L. Haertle, S. Barrio, U. Munawar, Seung-Bin Han +25 more
2022Clinical Cancer Research15 citations Open access
Semantic Scholar
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes
M. Lionetti, Margherita Scopetti, Antonio Matera, Akihiro Maeda +22 more
2025Blood14 citations Open access
Semantic Scholar
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification
V. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio +16 more
2023Haematologica14 citations Open access
Semantic Scholar
The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”
Antonio Giovanni Solimando, M. da Via, N. Bolli, Torsten Steinbrunn
2022Cancers13 citations Open access
Semantic Scholar
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
Marco Manzoni, A. Bosi, S. Fabris, M. Lionetti +13 more
2022Clinical Hematology International13 citations Open access
Semantic Scholar
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort
M. da Via, M. Lionetti, A. Marella, Antonio Matera +13 more
2022Blood Advances12 citations Open access
Semantic Scholar
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion.
Barbara Bassani, G. Simonetti, V. Cancila, A. Fiorino +21 more
2024Cell Reports11 citations Open access
Semantic Scholar
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort
D. Cattaneo, C. Bucelli, A. Marchetti, M. Lionetti +12 more
2023Annals of Hematology11 citations
Semantic Scholar
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma
M. da Via, Francesca Lazzaroni, Antonio Matera, A. Marella +26 more
2025Blood10 citations Open access
Semantic Scholar
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma
Antonio Matera, A. Marella, A. Maeda, M. da Via +14 more
2022International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
C. Botta, Emilia Gigliotta, B. Paiva, R. Anselmo +14 more
2022Hematological Oncology9 citations Open access
Semantic Scholar
What Is New in the Treatment of Smoldering Multiple Myeloma?
N. Bolli, N. Sgherza, P. Curci, R. Rizzi +7 more
2021Journal of Clinical Medicine9 citations Open access
Semantic Scholar
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
B. Fattizzo, A. Marchetti, Alessandro Bosi, C. Gurnari +24 more
2024Blood Advances8 citations Open access
Semantic Scholar
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma
N. Puccio, G. Manzotti, Elisabetta Mereu, Federica Torricelli +15 more
2024Haematologica8 citations Open access
Semantic Scholar
Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
B. Rodriguez-Martin, Eva G. Álvarez, Adrian Baez-Ortega, Jorge Zamora +47 more
2023Nature Genetics8 citations Open access
Semantic Scholar
Enhanced dynamic risk stratification of smoldering multiple myeloma
F. Chabrun, D. Schwartz, Susanna Gentile, E. Mai +44 more
2026Nature Medicine7 citations Open access
Semantic Scholar
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma
A. Poletti, B. Taurisano, G. Mazzocchetti, M. Lionetti +20 more
2025Haematologica6 citations Open access
Semantic Scholar
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data
E. Martino, A. Pitino, M. Offidani, R. Della Pepa +61 more
2025Haematologica6 citations Open access
Semantic Scholar
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma
M. Resnati, Sara Pennacchio, Lisa Viviani, T. Perini +10 more
2024Haematologica6 citations Open access
Semantic Scholar
ZEB1 shapes AML immunological niches suppressing CD8 T-cell activity while fostering Th17 cell expansion
B. Bassani, G. Simonetti, V. Cancila, M. Ciciarello +17 more
2023bioRxiv6 citations Open access
Semantic Scholar
European Myeloma Network Group Consensus Statement on the use of next‐generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
N. Bolli, M. D'Agostino, T. Bagratuni, M. Boccadoro +28 more
2025HemaSphere5 citations Open access
Semantic Scholar
Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes
E. Sauta, M. Robin, M. Bersanelli, E. Travaglino +44 more
2022Blood5 citations Open access
Semantic Scholar
Single cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment
Nicolas A. Gort-Freitas, Maria Moscvin, M. da Via, Francesca Lazzaroni +21 more
2025Blood4 citations Open access
Semantic Scholar
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing
B. Fattizzo, M. da Via, Francesca Lazzaroni, A. Marchetti +7 more
2025Signal Transduction and Targeted Therapy4 citations Open access
Semantic Scholar
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma
N. Platonova, Elisa Lazzari, M. Colombo, M. Falleni +11 more
2023International Journal of Molecular Sciences4 citations Open access
Semantic Scholar
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.
B. Ziccheddu, Claudia Giannotta, M. D'Agostino, G. Bertuglia +14 more
2023medRxiv4 citations Open access
Semantic Scholar
Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E. Davies, M. Samur, J. Corre +42 more
2025Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life Application.
Roberto Mina, Elisabetta Antonioli, G. Barilà, N. Bolli +11 more
2025Clinical Lymphoma, Myeloma & Leukemia3 citations
Semantic Scholar
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma
D. Ronchetti, V. Favasuli, I. Silvestris, K. Todoerti +5 more
2022Discover Oncology3 citations Open access
Semantic Scholar
Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma
Francesco Maura, A. Rajanna, A. Derkach, B. Ziccheddu +24 more
2022Blood3 citations Open access
Semantic Scholar
The absence of IL17A favours cytotoxic cell function and improves antigen‐specific immunotherapies in pancreatic adenocarcinoma
G. Tiberi, A. Scagliotti, Claudia Curcio, E. Candiello +14 more
2025Clinical and Translational Medicine2 citations Open access
Semantic Scholar
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients
F. Morabito, E. Martino, M. Galli, M. Offidani +63 more
2025European Journal of Haematology2 citations Open access
Semantic Scholar
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, D. Schwartz, Susanna Gentile, E. Mai +44 more
2025Research Square2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. da Via×13
Invite
M. da Via — researcher profile on SciRah
A. Neri×10
Invite
A. Neri — researcher profile on SciRah
Francesco Maura×9
Invite
Francesco Maura — researcher profile on SciRah
A. Marella×9
Invite
A. Marella — researcher profile on SciRah

×8

Invite

B. Ziccheddu — researcher profile on SciRah

Claudio de Magistris×8

Invite

Claudio de Magistris — researcher profile on SciRah

Loredana Pettine×8

Invite

Loredana Pettine — researcher profile on SciRah

Invite

B. Diamond — researcher profile on SciRah

D. Ronchetti×7

Invite

D. Ronchetti — researcher profile on SciRah

Invite

E. Taiana — researcher profile on SciRah

Invite

E. Zamagni — researcher profile on SciRah

Invite

A. Neri — researcher profile on SciRah